A New Class of Blue‐LED‐Excitable NIR‐II Luminescent Nanoprobes Based on Lanthanide‐Doped CaS Nanoparticles. Issue 28 (5th June 2019)

• Record Type: Journal Article
• Authors: Zhang, Meiran; Zheng, Wei; Liu, Yan; Huang, Ping; Gong, Zhongliang; Wei, Jiaojiao; Gao, Yu; Zhou, Shanyong; Li, Xingjun; Chen, Xueyuan
• Is Part Of: Angewandte Chemie international edition. Volume 58:Issue 28(2019)
• Page Start: 9556
• Page End: 9560
• Publication Date: 2019-06-05
• Subjects: biosensors -- CaS -- lanthanides -- nanoprobes -- near-infrared-II luminescence; Chemistry -- Periodicals; 540
• DOI: 10.1002/anie.201905040
• Languages: English
• ISSNs: 1433-7851

Abstract

Abstract: Lanthanide (Ln 3+ )‐doped luminescent nanoparticles (NPs) with emission in the second near‐infrared (NIR‐II) biological window have shown great promise but their applications are currently limited by the low absorption efficiency of Ln 3+ owing to the parity‐forbidden 4f→4f electronic transition. Herein, we developed a strategy for the controlled synthesis of a new class of NIR‐II luminescent nanoprobes based on Ce 3+ /Er 3+ and Ce 3+ /Nd 3+ co‐doped CaS NPs, which can be effectively excited by using a low‐cost blue light‐emitting diode chip. Through sensitization by the allowed 4f→5d transition of Ce 3+, intense NIR‐II luminescence from Er 3+ and Nd 3+ with quantum yields of 9.3 % and 7.7 % was achieved, respectively. By coating them with a layer of amphiphilic phospholipids, these NPs exhibit excellent stability in water and can be exploited as sensitive NIR‐II luminescent nanoprobes for the accurate detection of an important disease biomarker, xanthine, with a detection limit of 32.0 nm . Abstract : A new class of NIR‐II luminescent nanoprobes, which can be excited by using a low‐cost blue‐LED chip, was developed based on efficient energy transfer from Ce 3+ to Er 3+ and Nd 3+ in CaS nanoparticles with quantum yields up to 9.3 % and 7.7 % for Er 3+ and Nd 3+, respectively. These phospholipid‐coated CaS:Ce 3+, Er 3+ nanoprobes were used for the sensitive and specific detection of the disease biomarker xanthine.